Canadian Journal of Microbiology/Revue Canadienne de Microbiologie 2012-07-01

Viral protease inhibitors affect the production of virulence factors in Cryptococcus neoformans.

J J C Sidrim, L V Perdigão-Neto, R A Cordeiro, R S N Brilhante, J J G Leite, C E C Teixeira, A J Monteiro, R M F Freitas, J F Ribeiro, J R L Mesquita, M V F Gonçalves, M F G Rocha

Index: Can. J. Microbiol. 58(7) , 932-6, (2012)

Full Text: HTML

Abstract

The effects of the protease inhibitors saquinavir, darunavir, ritonavir, and indinavir on growth inhibition, protease and phospholipase activities, as well as capsule thickness of Cryptococcus neoformans were investigated. Viral protease inhibitors did not reduce fungal growth when tested in concentrations ranging from 0.001 to 1.000 mg/L. A tendency toward increasing phospholipase activity was observed with the highest tested drug concentration in a strain-specific pattern. However, these drugs reduced protease activity as well as capsule production. Our results confirm a previous finding that antiretroviral drugs affect the production of important virulence factors of C. neoformans.


Related Compounds

Related Articles:

Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.

2014-11-20

[Int. J. Pharm. 475(1-2) , 191-7, (2014)]

Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.

2012-03-15

[Cell Cycle 11(6) , 1174-82, (2012)]

Can inhibition of proteasomes or NF-kappaB help control idiopathic nephrotic syndrome?

2012-05-01

[Nephrol. Dial. Transplant. 27(5) , 1698-701, (2012)]

Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.

2013-06-15

[J. Neuroimmunol. 259(1-2) , 55-65, (2013)]

Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.

2012-09-01

[J. Pharm. Sci. 101(9) , 3199-213, (2012)]

More Articles...